FIB991

Asset

Blocks the YAP/TAZ pathway, shutting down fibroblast activation and stopping fibrosis progression.

Stage
Preclinical
Modality
Small molecule
Target
Not known
2
Indications
0
Trials
1
Developer

Indications

2

In the full profile

  • Owner and partners1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets